- Exchange: BSE India
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharmaceuticals
Aarey Drugs & Pharmaceutical
+ Add to WatchlistAD:IN
20.90 INR 0.15 0.72%As of 06:11:22 ET on 06/18/2013.
Snapshot for Aarey Drugs & Pharmaceutical (AD)
| Open: | 20.50 | Day's Range: | 20.35 - 21.15 | Volume: | 23,410 |
|---|---|---|---|---|---|
| Previous Close: | 20.75 | 52wk Range: | 12.40 - 71.60 | 1-Yr Rtn: | -2.03% |
Key Statistics for AD
| Current P/E Ratio (ttm) | 53.5897 |
|---|---|
| Estimated P/E(-) | - |
| Relative P/E vs. SENSEX | 3.4695 |
| Earnings Per Share (ttm) | 0.3900 |
| Est. EPS | - |
| Est. PEG Ratio | - |
| Market Cap (M INR) | 351.43 |
| Shares Outstanding (M) | 16.81 |
| 30 Day Average Volume | 21,296 |
| Price/Book (mrq) | 1.0710 |
| Price/Sale (ttm) | 0.2040 |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 08/14/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for AD
Company Profile & Key Executives for AD
Aarey Drugs & Pharmaceuticals manufactures 2 methyl -5-nitro imidazol, a pharmaceutical intermediate and curing agent in polyurethane and epoxy resins, and metronidazole, an anti-infective.
| Mihir R GhataliaManaging Director | Lalit Radhakrishna TulsianiExecutive Director |
| Sweta PoddarCompliance Officer |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
AD News
-
Industry News
No stories found
Advertisement
- 1
- 2
- 3
- 4
- 5
Advertisement
Sponsored Links
Advertisements
Rate this Page